NCT07733401

Brief Summary

The goal of this clinical trial is to learn whether expansile duraplasty can improve neurological recovery in adult patients with acute severe traumatic spinal cord injury, as well as evaluate the safety of this surgical strategy. The main questions the study aims to answer are:

  1. 1.Does expansile duraplasty lead to superior motor function recovery in patients with acute severe traumatic spinal cord injury?
  2. 2.How safe is the use of expansile duraplasty in people with acute traumatic SCI?
  3. 3.Receive standardized spinal surgery ;
  4. 4.Provide blood and cerebrospinal fluid samples during hospitalization;
  5. 5.Undergo spinal computed tomography (CT) and magnetic resonance imaging (MRI) scans at baseline (pre-operation), discharge, 3 months, 6 months and 12 months after surgery;
  6. 6.Complete standardized neurological assessments at 3, 6 and 12 months postoperatively, including ASIA motor and sensory scores, Walking Index for Spinal Cord Injury II (WISCI II), and Spinal Cord Independence Measure III (SCIM III);
  7. 7.Fill out questionnaires at each follow-up visit, including the 36-Item Short Form Health Survey (SF-36);
  8. 8.Be continuously monitored for all adverse events and surgical complications throughout the 12-month follow-up period.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
37mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

13 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 29, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2029

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2029

Last Updated

July 29, 2026

Status Verified

July 1, 2026

Enrollment Period

3 years

First QC Date

July 24, 2026

Last Update Submit

July 24, 2026

Conditions

Keywords

Acute Spinal Cord Injury

Outcome Measures

Primary Outcomes (1)

  • Change in AIS motor score

    Change in American Spinal Injury Association Impairment Scale total limb motor score at 6 months

    6 months versus baseline

Secondary Outcomes (6)

  • Change in AIS motor score

    3,12 months versus baseline

  • Change in AIS grade

    3,6,12 months versus baseline

  • WISCI II

    3,6,12 months

  • SCIM III

    3,6,12 months

  • SF-36

    3,6,12 months

  • +1 more secondary outcomes

Other Outcomes (4)

  • Incidence of adverse events

    From enrollment to 12 months post-injury

  • Mortality

    From enrollment to 12 months post-injury

  • Length of hospital stay

    12 months post-injury

  • +1 more other outcomes

Study Arms (2)

Expansile duraplasty

EXPERIMENTAL

Participants in this arm receive expansile duraplasty during their standard surgery for spinal cord injury.

Procedure: Expansile duraplasty

No expansile duraplasty

NO INTERVENTION

Participants in this arm do not receive expansile duraplasty during their standard surgery for spinal cord injury.

Interventions

For participants receiving expansile duraplasty during standard spinal surgery, the dura mater is longitudinally incised along the midline, followed by watertight augmented repair with autologous fascial graft to expand the intrathecal space and accommodate edematous spinal cord after trauma. The length of the dural incision matches the extent of spinal cord edema shown on preoperative MRI. This duraplasty procedure is performed concurrently with the index surgery for traumatic spinal cord injury, rather than as a staged or delayed secondary operation. The pia mater and spinal cord parenchyma remain intact and are not incised intraoperatively.

Expansile duraplasty

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 18 and 80 years old, with no restrictions on gender;
  • Patients diagnosed with traumatic cervical or thoracic spinal cord injury (C2-T12) via clinical evaluation including medical history collection, physical examination and auxiliary imaging tests;
  • Classified as Grade A, B or C according to the ASIA Impairment Scale (AIS) based on the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI);
  • Scheduled to receive surgical intervention within 72 hours after traumatic spinal cord injury;
  • Preoperative T2-weighted MRI shows no cerebrospinal fluid signal between the spinal cord and dura mater at a minimum of one vertebral segment;
  • Good general physical condition with an expected survival time of no less than 12 months;
  • Voluntarily participate in this trial, sign the written informed consent form, exhibit good compliance and cooperate with all follow-up visits;
  • Judged by attending surgeons to meet the surgical indications for posterior laminectomy and spinal internal fixation, with surgical decision-making based on surgeons' clinical experience.

You may not qualify if:

  • Transverse spinal cord injury;
  • Gunshot or penetrating sharp spinal cord injury;
  • Pre-existing dural laceration caused by traumatic spinal cord injury;
  • Spinal cord injury without radiographic abnormality (SCIWORA, spinal injury without fracture or dislocation);
  • Acute exacerbation of pre-existing chronic spinal cord injury;
  • Traumatic spinal cord injury complicated with epidural or subdural hematoma;
  • Severe concomitant traumatic brain injury defined as a Glasgow Coma Scale (GCS) score \< 14; patients unable to follow simple verbal commands due to altered mental status; or patients with clinically significant abnormalities on cranial CT (only patients with suspected brain injury identified by investigators require cranial CT scanning);
  • Presence of underlying comorbidities that contraindicate surgery or interfere with accurate medical and neurological assessments (judged by the principal investigator).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Xuanwu Hospital, Capital Medical University

Beijing, Beijing Municipality, 100053, China

Location

Beijing Jiangong Hospital

Beijing, Beijing Municipality, China

Location

Beijing Shuili Hospital

Beijing, Beijing Municipality, China

Location

The Third Affiliated Hospital of Southern Medical University

Guangzhou, Guangdong, China

Location

Gaozhou Hospital of Traditional Chinese Medicine, Guangdong Province

Maoming, Guangdong, China

Location

Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine

Cangzhou, Hebei, China

Location

The First Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Location

Xuanwu Hospital Inner Mongolia Hospital (Chifeng City Hospital)

Chifeng, Inner Mongolia, China

Location

Shandong University Qilu Hospital (Dezhou Branch)

Dezhou, Shandong, 253001, China

Location

Jinan Central Hospital, Affiliated to Shandong First Medical University

Jinan, Shandong, China

Location

Liaocheng Brain Hospital

Liaocheng, Shandong, China

Location

Shanxi Provincial People's Hospital

Taiyuan, Shanxi, China

Location

Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, China

Location

Related Publications (6)

  • Li YC, Chen KH, Li CY, Lu YJ. The outcome of injured cervical spinal cord with uncontrolled swelling under duraplasty: protocol of the ISCUD randomized controlled trial. Trials. 2025 Dec 2;26(1):559. doi: 10.1186/s13063-025-09288-6.

    PMID: 41331929BACKGROUND
  • Saadoun S, Grassner L, Belci M, Cook J, Knight R, Davies L, Asif H, Visagan R, Gallagher MJ, Thome C, Hutchinson PJ, Zoumprouli A, Wade J, Farrar N, Papadopoulos MC. Duroplasty for injured cervical spinal cord with uncontrolled swelling: protocol of the DISCUS randomized controlled trial. Trials. 2023 Aug 7;24(1):497. doi: 10.1186/s13063-023-07454-2.

    PMID: 37550727BACKGROUND
  • Greil ME, Hunt ER, Torres Espin A, Saigal R. Retrospective Analysis of Expansile Duraplasty as Surgical Adjunct After Acute Traumatic Spinal Cord Injury. Global Spine J. 2026 Mar;16(2):1212-1220. doi: 10.1177/21925682251376321. Epub 2025 Sep 4.

    PMID: 40906933BACKGROUND
  • Zhu F, Yao S, Ren Z, Telemacque D, Qu Y, Chen K, Yang F, Zeng L, Guo X. Early durotomy with duroplasty for severe adult spinal cord injury without radiographic abnormality: a novel concept and method of surgical decompression. Eur Spine J. 2019 Oct;28(10):2275-2282. doi: 10.1007/s00586-019-06091-1. Epub 2019 Aug 22.

    PMID: 31440894BACKGROUND
  • Saadoun S, Werndle MC, Lopez de Heredia L, Papadopoulos MC. The dura causes spinal cord compression after spinal cord injury. Br J Neurosurg. 2016 Oct;30(5):582-4. doi: 10.3109/02688697.2016.1173191. Epub 2016 Apr 15.

    PMID: 27080553BACKGROUND
  • Werndle MC, Saadoun S, Phang I, Czosnyka M, Varsos GV, Czosnyka ZH, Smielewski P, Jamous A, Bell BA, Zoumprouli A, Papadopoulos MC. Monitoring of spinal cord perfusion pressure in acute spinal cord injury: initial findings of the injured spinal cord pressure evaluation study*. Crit Care Med. 2014 Mar;42(3):646-55. doi: 10.1097/CCM.0000000000000028.

    PMID: 24231762BACKGROUND

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Wanru Duan, MD

    Xuanwu Hospital, Beijing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2026

First Posted

July 29, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2029

Study Completion (Estimated)

September 1, 2029

Last Updated

July 29, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations